A multi-source fusion method to identify biomarkers for breast cancer prognosis based on dual-layer heterogeneous network. - Xingyi Li; Zhelin Zhao; Ju Xiang; Jialu Hu; Xuequn Shang 001 (BIBM, 2022)

SEPA: signaling entropy-based algorithm to evaluate personalized pathway activation for survival analysis on pan-cancer data. - Xingyi Li; Min Li 007; Ju Xiang; Zhelin Zhao; Xuequn Shang 001 (Bioinform., 2022)

A personalized pathway activation inference method based on pathway structure for classification of inflammatory bowel disease. - Xingyi Li; Xuequn Shang 001; Zhelin Zhao; Chenzhuo Yan (BIBM, 2023)

PathActMarker: an R package for inferring pathway activity of complex diseases. - Xingyi Li; Jun Hao; Zhelin Zhao; Junming Li; Xingyu Liao; Min Li 007; Xuequn Shang 001 (Frontiers Comput. Sci., 2025)